Integrating Newborn Screening Laboratory Data with Birth Defects Registries and Other Public Health Programs

Russell S Kirby1

  • 1Department of Community Health Sciences, College of Public Health, University of South Florida, Tampa, FL, United States.

Clinical Chemistry
|December 30, 2025
PubMed

Insights

Integrating newborn screening and genetic testing data with birth defects registries can enhance public health surveillance. This approach improves the characterization of metabolic disorders and phenotypic variations in infants.

Area of Science:

  • Public Health
  • Genetics
  • Medical Informatics

Background:

  • Birth defects registries aim to identify major birth defects in infants within the first year of life.
  • Existing public health programs track special needs and developmental disabilities.
  • Newborn screening programs, though population-based and identifying birth defects, are often excluded from birth defects registries.

Purpose of the Study:

  • To explore integrating laboratory screening and diagnostic data with birth defects registries and public health programs.
  • To enhance surveillance of infant metabolic disorders.
  • To better characterize phenotypic variation in infants with metabolic disorders.

Main Methods:

  • Review of current data collection practices in birth defects registries and newborn screening programs.
  • Analysis of opportunities for data linkage and integration.
  • Exploration of methods to incorporate laboratory data into public health surveillance systems.

Main Results:

  • Integration of laboratory data can significantly improve the comprehensiveness of birth defects surveillance.
  • Enhanced data sharing allows for better identification and tracking of infants with metabolic disorders.
  • Improved characterization of phenotypic variations associated with screened conditions.

Conclusions:

  • Utilizing laboratory data from newborn screening and genetic testing is crucial for advancing birth defects surveillance.
  • Data integration strengthens public health programs by providing a more complete picture of infant health.
  • This approach supports more accurate phenotyping and improved public health outcomes for infants with metabolic disorders.
Abstract

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.5K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.4K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
439
Pedigree Analysis01:35

Pedigree Analysis

Overview
88.7K